Index of reports
> Cases with Fall (80)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mirtazapine where reactions include fall. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 80 Next >>
Possible Mirtazapine side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17
Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1 mg, tid, 1mg three times per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-29
End date: 2012-05-23
Metoclopramide Hydrochloride
Dosage: 10 mg, as required
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-06
End date: 2011-09-01
Mirtazapine
Dosage: 30 mg, daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Paroxetine HCL
Dosage: 20 mg, bid
Administration route: Oral
Indication: Depression
Start date: 1997-07-07
End date: 2011-12-06
Propranolol
Dosage: 10 mg, 10mg six times per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Tetrabenazine
Dosage: 4.5 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-28
End date: 2012-03-20
Other drugs received by patient: Ramipril; Bendroflumethiazide; Beconase; Fenofibrate; Lansoprazole; Atorvastatin; Acrivastine
Possible Mirtazapine side effects in 69 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-08-16
Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-29
End date: 2012-05-23
Metoclopramide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-06
End date: 2011-09-01
Mirtazapine
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Mirtazapine
Paroxetine HCL
Administration route: Oral
Indication: Depression
Start date: 1997-07-07
Paroxetine HCL
Administration route: Oral
Start date: 2001-02-01
End date: 2010-05-01
Paroxetine HCL
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-06
Paroxetine HCL
Administration route: Oral
Start date: 2010-07-01
End date: 2011-09-01
Propranolol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Tetrabenazine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-28
End date: 2012-03-20
Other drugs received by patient: Atorvastatin; Beconase; Fenofibrate; Ramipril; Bendroflumethiazide; Lansoprazole; Acrivastine
Possible Mirtazapine side effects in 69 year old female
Reported by a physician from United Kingdom on 2012-08-14
Patient: 69 year old female, weighing 64.0 kg (140.8 pounds)
Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 3 milligram daily;
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-29
End date: 2012-05-23
Lorazepam
Dosage: 1.5 milligram daily;
Start date: 2011-01-01
Metoclopramide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-06
End date: 2011-09-01
Mirtazapine
Dosage: 30 milligram daily;
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Mirtazapine
Dosage: 15 milligram daily;
Paroxetine HCL
Administration route: Oral
Indication: Depression
Start date: 1997-07-07
End date: 2011-12-06
Paroxetine HCL
Dosage: .5 tablet daily;
Administration route: Oral
Start date: 2001-02-01
End date: 2010-05-01
Paroxetine HCL
Dosage: 40 milligram daily;
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-06
Paroxetine HCL
Dosage: 20 milligram daily;
Administration route: Oral
Start date: 2010-07-01
End date: 2011-09-01
Propranolol
Dosage: 60 milligram daily;
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Tetrabenazine
Dosage: 4.5 milligram daily;
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-28
End date: 2012-03-20
Other drugs received by patient: Lansoprazole; Atorvastatin; Acrivastine; Beconase; Bendroflumethiazide; Fenofibrate; Ramipril
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-27
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1 mg, tid, 1mg three times per day
Indication: Product Used FOR Unknown Indication
Metoclopramide Hydrochloride
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30 mg, daily
Indication: Product Used FOR Unknown Indication
Propranolol
Dosage: 10 mg, 10mg six times per day
Indication: Product Used FOR Unknown Indication
Seroxat
Dosage: 20 mg, bid, 20mg twice per day
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Tetrabenazine
Dosage: 4.5mg per day
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Atorvastatin; Omeprazole; Acrivastine; Fenofibrate; Bendroflumethiazide; Ramipril; Beconase
Possible Mirtazapine side effects in female
Reported by a physician from United Kingdom on 2012-07-26
Patient: female, weighing 64.0 kg (140.8 pounds)
Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1mg three times per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-29
End date: 2012-05-23
Metoclopramide
Dosage: 10mg as required
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-08-06
End date: 2011-09-01
Mirtazapine
Dosage: 30mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Paroxetine Hydrochloride
Administration route: Oral
Indication: Depression
Start date: 1997-07-07
End date: 2011-12-06
Propranolol
Dosage: 10mg six times per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-01
Tetrabenazine
Dosage: 4.5mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-28
End date: 2012-03-20
Other drugs received by patient: Acrivastine; Bendroflumethiazide; Ramipril; Lansoprazole; Beconase; Fenofibrate; Atorvastatin
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-26
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Indication: Product Used FOR Unknown Indication
Metoclopramide
Indication: Product Used FOR Unknown Indication
Mirtazapine
Mirtazapine
Indication: Product Used FOR Unknown Indication
Paroxetine Hydrochloride
Administration route: Oral
Paroxetine Hydrochloride
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Paroxetine Hydrochloride
Administration route: Oral
Start date: 2011-11-01
Propranolol
Indication: Product Used FOR Unknown Indication
Tetrabenazine
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Omeprazole; Beconase; Bendroflumethiazide; Fenofibrate; Ramipril; Acrivastine; Atorvastatin
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from Denmark on 2012-07-25
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Dyskinesia, Hypophagia, Hallucination, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1 mg;tid
Indication: Product Used FOR Unknown Indication
Metoclopramide Hydrochloride
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30 mg;qd
Indication: Product Used FOR Unknown Indication
Paroxetine HCL
Dosage: 20 mg;bid;po
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Propranolol HCL
Dosage: 10 mg;q4h
Indication: Product Used FOR Unknown Indication
Tetrabenazine (Tetrabenazine)
Dosage: 4.5 mg;qd
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Beconase; Acrivastine; Omeprazole; Fenofibrate; Bendroflumethiazide; Ramipril; Atorvastatin
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-25
Patient: female
Reactions: Akathisia, Drug Effect Decreased, Joint Contracture, Adverse Drug Reaction, Dyskinesia, General Physical Health Deterioration, Fall, Hypophagia, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1 mg, tid, dose halved
Indication: Product Used FOR Unknown Indication
Metoclopramide Hydrochloride
Dosage: df
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30 mg, frequency unspecifieid, 15 mg, qd
Indication: Product Used FOR Unknown Indication
Paroxetine Hydrochloride
Paroxetine Hydrochloride
Dosage: 20 mg qd, oral, 20 mg, bid, oral (1 tablet dosage unknown, (half a tablet) (dose and frequency unspe
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
End date: 2011-11-01
Propranolol
Dosage: 10 mg, 6xday
Indication: Product Used FOR Unknown Indication
Tetrabenazine (Tetrabenazine)
Dosage: 4.5 mg, qd
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Bendroflumethiazine; Omeprazole; Ramipril; Actrivastine; Fenofibrate; Atorvastatin Calcium; Beconase
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-25
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Indication: Product Used FOR Unknown Indication
Lorazepam
Dosage: 1.5 milligram;
Start date: 2011-01-01
Metoclopramide
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30 milligram;
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 15 milligram;
Paroxetine Hydrochloride
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Paroxetine Hydrochloride
Dosage: 20 milligram;
Administration route: Oral
Start date: 2011-01-01
Propranolol
Indication: Product Used FOR Unknown Indication
Tetrabenazine
Dosage: 4.5 milligram;
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Fenofibrate; Ramipril; Atorvastatin; Beconase; Omeprazole; Acrivastine; Bendroflumethiazide
Possible Mirtazapine side effects in female
Reported by a individual with unspecified qualification on 2012-07-24
Patient: female
Reactions: Akathisia, Drug Effect Decreased, Joint Contracture, Dyskinesia, Adverse Drug Reaction, General Physical Health Deterioration, Fall, Hypophagia, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 3 mg (1 mg, 3 in 1 d)
Indication: Product Used FOR Unknown Indication
Metoclopramide
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30 mg, daily
Indication: Product Used FOR Unknown Indication
Paroxetine HCL
Dosage: 40 mg (20 mg, 2 in 1 d), oral, 20 mg (20 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Depression
Start date: 2011-01-01
End date: 2011-11-01
Paroxetine HCL
Dosage: 40 mg (20 mg, 2 in 1 d), oral, 20 mg (20 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Propranolol
Dosage: 60 mg (10 mg, 6 in 1 d)
Indication: Product Used FOR Unknown Indication
Tetrabenazine (Tetrabenazine)
Dosage: 4.5 mg daily
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Beconase; Ramipril; Omeprazole; Acrivastine (Acrivastine); Atorvastatin; Fenofibrate; Bendroflumethiazide (Bendroflumethiazide)
Possible Mirtazapine side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-23
Patient:
Reactions: Akathisia, Muscle Contractions Involuntary, Fall, Hallucination, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1 mg, tid
Metoclopramide
Mirtazapine
Dosage: 15 mg, qd
Mirtazapine
Dosage: 30 mg, unk
Paroxetine Hydrochloride
Dosage: 20 mg, bid
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Propranolol Hydrochloride
Dosage: 10 mg, q4h
Tetrabenazine
Dosage: 4.5 mg, qd
Other drugs received by patient: Acrivastine; Beconase; Atorvastatin Calcium; Fenofibrate; Ramipril; Bendrofluazide Tablets; Omeprazole
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-06
Patient: female, weighing 103.0 kg (226.6 pounds)
Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Overdose, Myoglobin Blood Increased, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: 1+0+0+1.5 (6 millimoles)
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 80 mg
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-07-05
Patient: 72 year old female
Reactions: Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Constipation, Fall, Liver Disorder, Multi-Organ Failure, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Polydipsia, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol;unk;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Curetter; Kalimklorid; Centyl MED
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-03
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1mg three times per day
Indication: Product Used FOR Unknown Indication
Metoclopramide
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30mg per day
Indication: Product Used FOR Unknown Indication
Paroxetine Hydrochloride
Dosage: 20mg twice per day
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Propranolol
Dosage: 10mg six times per day
Indication: Product Used FOR Unknown Indication
Tetrabenazine
Dosage: 4.5mg per day
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Omeprazole; Ramipril; Bendroflumethiazide; Acrivastine; Fenofibrate; Beconase; Atorvastatin
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-29
Patient: female
Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-28
Patient: female
Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol, unk
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone HCL
Dosage: 40 mg, bid
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Centyl MED Kaliumklorid; Fragmin; Ferro Duretter; Amlodipine Actavis; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-26
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Fall, Organ Failure, Multi-Organ Failure, Hyperventilation, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: K CL TAB; Ferro Duretter; Alprazolam
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-22
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Confusional State, Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Centyl K; Ferro Duretter; Alprazolam
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-22
Patient: female
Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cipralex
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22
Patient: female
Reactions: Confusional State, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Escitalopram
Dosage: 30 mg, qd
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Dosage: 1.5 df (in the evening)
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Dosage: 1 df (in the morning)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid
Administration route: Oral
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Alprazolam; Centyl MED Kaliumklorid; Ferro Duretter
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-22
Patient: 72 year old female
Reactions: Confusional State, Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Pyrexia, Serotonin Syndrome, Constipation, Fall, Hyperventilation, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, General Physical Health Deterioration, Organ Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 6 mmol, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid, po
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED; Kaliumklorid
Possible Mirtazapine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-06-20
Patient: female
Reactions: Akathisia, Muscle Contractions Involuntary, Hallucination, Fall, Eating Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lorazepam
Dosage: 1mg three times per day
Indication: Product Used FOR Unknown Indication
Metoclopramide
Indication: Product Used FOR Unknown Indication
Mirtazapine
Dosage: 30mg per day
Indication: Product Used FOR Unknown Indication
Paroxetine Hydrochloride
Dosage: 20mg twice per day
Administration route: Oral
Indication: Depression
Start date: 2011-11-01
Propranolol
Dosage: 10mg six times per day
Indication: Product Used FOR Unknown Indication
Tetrabenazine
Dosage: 4.5mg per day
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Acrivastine; Fenofibrate; Bendroflumethiazide; Beconase; Omeprazole; Ramipril; Atorvastatin Calcium
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-19
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Rhabdomyolysis, Serotonin Syndrome, Lactic Acidosis, Constipation, Fall, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Lacunar Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram Oxalate
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Lithium Citrate
Dosage: po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg;qd;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg;bid;po
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2005-01-01
End date: 2011-10-23
Other drugs received by patient: Ferro Duretter; Alprazolam; K CL TAB
Possible Mirtazapine side effects in female
Reported by a physician from Denmark on 2012-06-15
Patient: female
Reactions: Confusional State, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Hypertension
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1 df (in the morning)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1.5 df (in the evening)
Administration route: Oral
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2011-01-01
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: styrke: 40 mg
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED Kaliumklorid
Possible Mirtazapine side effects in 88 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-12
Patient: 88 year old female
Reactions: Confusional State, Blood Pressure Systolic Increased, Urinary Tract Infection, Drug Interaction, Abnormal Behaviour, Cognitive Disorder, Disorientation, Fall, Aggression, Incoherent, Blood Sodium Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Imovane (Zopiclone)
Dosage: 3.75 mg;qd;po
Administration route: Oral
Start date: 2012-01-06
Memantine HCL
Dosage: 10 mg;qd;po
Administration route: Oral
Indication: Senile Dementia
Start date: 2012-01-12
End date: 2012-01-20
Mirtazapine
Dosage: 15 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
Oxazepam
Dosage: 10 mg;bid;po
Administration route: Oral
Indication: Abnormal Behaviour
Start date: 2011-12-01
Zyprexa
Dosage: 5 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-24
Zyprexa
Dosage: 5 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-11
End date: 2012-01-20
Other drugs received by patient: Aspirin; Moviprep; Furadantin; Vitamin D; Acetaminophen
Possible Mirtazapine side effects in 72 year old female
Reported by a physician from Denmark on 2012-06-11
Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)
Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, daily
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Fragmin; Ferro Duretter; Amlodipine; Centyl K; Furosemide
Possible Mirtazapine side effects in 85 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-05
Patient: 85 year old female
Reactions: Weight Decreased, Psychomotor Retardation, Blood Pressure Systolic Increased, Hyponatraemia, General Physical Health Deterioration, Cerebral Atrophy, Coma Scale Abnormal, Disorientation, Fall, Mixed Receptive-Expressive Language Disorder, Psychiatric Symptom, Malignant Peritoneal Neoplasm, Asthenia, Blood Glucose Increased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Dosage: 15 mg;qd;po
Administration route: Oral
Indication: Depression
End date: 2012-01-27
Spironolactone
Dosage: 1 df;qd;po
Administration route: Oral
Indication: Hypertension
End date: 2012-01-27
Stalevo 50
Dosage: po 5 df;qd;po
Administration route: Oral
Indication: Parkinson's Disease
End date: 2011-12-01
Stalevo 50
Dosage: po 5 df;qd;po
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-15
End date: 2012-01-26
Other drugs received by patient: Polyethylene Glycol; Rabeprazole Sodium; Clopidogrel; Imovane; Lactulose; Oxazepam; Pravastatin
Possible Mirtazapine side effects in 88 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24
Patient: 88 year old female
Reactions: Blood Pressure Increased, Confusional State, Abnormal Behaviour, Drug Interaction, Condition Aggravated, Cognitive Disorder, Disorientation, Fall, Incoherent, Blood Sodium Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Flovent HFA
Dosage: 5 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-24
Flovent HFA
Dosage: 5 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-11
End date: 2012-01-20
Imovane (Zopiclone)
Dosage: 3.75 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
Memantine HCL
Dosage: 10 mg; qd; po
Administration route: Oral
Indication: Senile Dementia
Start date: 2012-01-12
End date: 2012-01-20
Mirtazapine
Dosage: 15 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-06
Oxazepam
Dosage: 10 mg; bid; po
Administration route: Oral
Indication: Abnormal Behaviour
Start date: 2011-12-01
Other drugs received by patient: Moviprep; Acetaminophen; Aspirin; Vitamin D; Furadantin
Possible Mirtazapine side effects in 33 year old male
Reported by a physician from Japan on 2012-04-20
Patient: 33 year old male
Reactions: Contusion, Toxicity To Various Agents, Fall, Loss of Consciousness, Sedation, Suicide Attempt, Multiple Drug Overdose Intentional, Oxygen Saturation Decreased, Haematoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mirtazapine
Dosage: 15;30 mg, qd, po
Administration route: Oral
Indication: Depression
Start date: 2012-03-06
End date: 2012-03-26
Mirtazapine
Dosage: 15;30 mg, qd, po
Administration route: Oral
Indication: Depression
Start date: 2012-02-21
End date: 2012-03-05
Rohypnol (Flunitrazepam)
Dosage: 2 mg, qd, po
Administration route: Oral
Indication: Depression
Start date: 2012-02-07
End date: 2012-03-26
Other drugs received by patient: Duloxetine Hydrochloride; Hydrochloride; Duloxetine Hydrochloride; Flunitrazepam; Duloxetine Hydrochloride; Hydrochloride; Hydrochloride
Possible Mirtazapine side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-13
Patient: female
Reactions: Humerus Fracture, Dyspnoea, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension, Myocardial Infarction, Cardiac Hypertrophy
Adverse event resulted in: death
Drug(s) suspected as cause:
Escitalopram
Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1 df (in the morning)
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Lithium Citrate
Dosage: 1.5 df (in the evening)
Administration route: Oral
End date: 2011-10-23
Lithium Citrate
Dosage: dosis: 1+0+0+1.5, styrke: 6 mmol li+
Administration route: Oral
End date: 2011-10-23
Mirtazapine
Dosage: 30 mg, qd
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: 40 mg, bid
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2011-10-23
Ziprasidone Hydrochloride
Dosage: styrke: 40 mg
Administration route: Oral
End date: 2011-10-23
Other drugs received by patient: Alprazolam; Amlodipine; Fragmin; Centyl MED Kaliumklorid; Ferro Duretter; Furosemide
Page 1 Next >>
|